|  Find a Doctor   |  Getting to NUHCS   | Appointment   | Contact Us   | Newsroom  |  Make a Gift  | About NUHS  | Protecting Your Data
 
 

Home > Our Doctors > Our Doctors > Department of Cardiology > Assistant Professor Joshua Loh

Assistant Professor Joshua Loh

 

MBBS (S’pore), M Med (Int Med), FRCP (Edin), FACC, FSCAI

 

 

Consultant Department of Cardiology, NUHCS

Assistant Professor in Medicine Yong Loo Lin School of Medicine, NUS

 


Assistant Professor Joshua Loh is presently a Consultant at the National University Heart Centre, Singapore, and an Assistant Professor at the Yong Loo Lin School of Medicine, Singapore.

 

Asst. Prof. Loh graduated with the degrees of Bachelor of Medicine and Surgery from the National University of Singapore in 2003. He was conferred the Master of Medicine in Internal Medicine from the National University of Singapore, and Membership of the Royal College of Physicians (United Kingdom) in 2007. He completed his Basic Specialist Training in Internal Medicine, and thereafter the Advanced Specialist Training in Cardiology at the National University Heart Centre, Singapore in 2010.

 

He was awarded the Academic Medicine Development Award (AMDA) and completed two years of advanced fellowship training in interventional cardiology and clinical research at the MedStar Washington Hospital Center and the MedStar Heart Research Institute, Washington, DC, USA. He was subsequently elected Fellow of the Royal College of Physicians (UK), Fellow of the American College of Cardiology, Fellow of the Society for Cardiovascular Angiography and Interventions (USA), Fellow of the Asean College of Cardiology, and Fellow of the Asian Pacific Society of Interventional Cardiology.

 

Asst. Prof. Loh has authored or co-authored more than 40 articles in peer-reviewed journals and has presented in international and regional scientific meetings. In addition, he has written book chapters and review articles in interventional cardiology. He is also serving in the Editorial Board for Singapore Medical Journal and Cardiovascular Revascularization Medicine, and is a manuscript reviewer in several medical journals.

 

Asst. Prof Loh is a Council Member of the Singapore Cardiac Society, and has been the Organizing Chairperson for the Annual Scientific Meeting since 2015.

 

Apart from general cardiology, Asst. Prof. Loh's specialty interests include coronary artery disease and acute coronary syndromes. He supervises the post- myocardial infarction clinic, concentrating on patient care after their heart attack. Asst. Prof. Loh performs cardiac catheterizations and percutaneous coronary interventions.

 

 

Specialty Interest(s):

  • Cardiac Catheterization
  • Percutaneous Coronary Intervention

 

Specializes in Diseases and Conditions:

  • Coronary Artery Disease
  • Acute Coronary Syndromes

 

 

Awards & Honors

  • Best case presentation, 20th TCTAP Cardiovascular Summit 2015
  • Best care presentation, 10th Asian Interventional Cardiovascular Therapeutics  2014
  • Top 10 Abstracts Award, Cardiovascular Research Technologies 2013
  • 1st Prize, Young Investigator’s Award, 18th ASEAN Congress of Cardiology 2010
  • 1st Prize, Best Abstract Award, 6th Asian Interventional and Cardiovascular Therapeutics 2010
  • 1st Runner-up, Young Investigator’s Award, 22nd Annual Scientific Meeting, Singapore Cardiac Society 2010
  • Finalist, Young Investigator’s Award, 22nd Annual Scientific Meeting, Singapore Cardiac Society 2010
  • Top 25 Posters Award, Transcatheter Cardiovascular Therapeutics 2009

 

Selected Publications

 

  1. Changes in the practice of cardiology: therapies at the forefront of science. Singapore Med J 2016;57:344-6. Loh JP, Poh KK. 

  2. Fever in a Patient with a Previous Gastrectomy. Ann Acad Med Singapore. 2016;45:117-120. Seow DG, Chan PF, Chia BL, Loh JP.

     
  3. Incidence and Correlates of Major Bleeding after Percutaneous Coronary Intervention across Different Clinical Presentations. Am Heart J 2014;168:248-255. Loh JP, Pendyala LK, Torguson R, Chen F, Satler LF, Pichard AD, Waksman R. Incidence

     
  4. Use of emergency medical services expedites in-hospital care processes in patients presenting with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovasc Revasc Med 2014;15:219-225. Loh JP, Satler LF, Pendyala LK, Minha S, Frohna WJ, Torguson R, Chen F, Suddath WO, Pichard AD, Waksman R.

     
  5. Comparison of Outcomes After Percutaneous Coronary Intervention Among Different Coronary Subsets (Stable and Unstable Angina Pectoris and ST-Segment and Non-ST-Segment Myocardial Infarction). Am J Cardiol 2014;113:1794-1801. Loh JP, Pendyala LK, Kitabata H, Torguson R, Omar A, Minha S, Chen F, Satler LF, Pichard AD, Waksman R.

     
  6. Impact of Early Versus Late Clopidogrel Discontinuation on Stent Thrombosis Following Percutaneous Coronary Intervention With First- and Second-Generation Drug-Eluting Stents.  Am J Cardiol 2014;113:1968-1976. Loh JP, Torguson R, Pendyala LK, Omar A, Chen F, Satler LF, Pichard AD, Waksman R.

     
  7. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. Cardiovasc Revasc Med 2014;15:23-28. Loh JP, Stella PR, Sangiorgi G, Silber S, Stahnke S, von Strandmann RP, Torguson R, Waksman R.

     
  8. The current status of drug-coated balloons in percutaneous coronary and peripheral interventions. EuroIntervention 2013;9:979-988. Loh JP, Barbash IM, Waksman R.

     
  9. A propensity score matched analysis to determine if second-generation drug-eluting stents outperform first-generation drug-eluting stents in a complex patient population. Int J Cardiol 2013;170:43-48. Loh JP, Pendyala LK, Kitabata H, Badr S, Torguson R, Chen F, Satler LF, Suddath WO, Pichard AD, Waksman R.

     
  10. Safety and feasibility of performing staged non-culprit vessel percutaneous coronary intervention within the index hospitalization in patients with ST-segment elevation myocardial infarction and multivessel disease. Cardiovasc Revasc Med 2013;14:258-263. Loh JP, Kitabata H, Torguson R, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
     

  11. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436-2441. Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, Ho MY, Kim HS, Loh JP, Oldroyd KG.
     

  12. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System. J Am Coll Cardiol. 2013;61:1571-1576. Loh JP, Barbash IM, Waksman R.
     

  13.  Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 2013;111:841-845. Loh JP, Pendyala LK, Kitabata H, Torguson R, Chen F, Kent KM, Satler LF, Suddath WO, Pichard AD, Waksman R.
     

  14.  Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv 2012;5:1001-1012. Loh JP, Waksman R.

 

 

For more publications, click here.

 

 Back to Top